Promentis Pharmaceuticals is a pharmaceutical company based in New York, New York, specializing in the development and delivery of innovative treatments. Located in the heart of Manhattan, the company focuses on advancing pharmaceutical research and creating solutions that address unmet medical needs. Its position in New York allows it to collaborate with a wide network of healthcare professionals, research institutions, and industry experts.
The company operates with a commitment to scientific rigor and quality, contributing to the pharmaceutical sector through the development of novel therapies. By leveraging cutting-edge technologies and methodologies, Promentis Pharmaceuticals aims to improve patient outcomes and support healthcare providers with effective treatment options. Its operations reflect a blend of research, clinical development, and regulatory expertise.
Situated at 35 W 35th St, the company’s New York location is a hub for its research and development activities. It maintains a focus on areas such as neuropsychiatric and neurological conditions, aligning with broader industry trends that emphasize targeted therapies and precision medicine. This focus enables Promentis Pharmaceuticals to address complex health challenges and contribute to ongoing advancements in pharmaceutical science.
As a participant in the competitive pharmaceutical landscape of New York City, Promentis Pharmaceuticals engages with various stakeholders to foster innovation and ensure compliance with industry standards. Contact can be made through its business phone number, 212-375-2665, reflecting its accessibility and commitment to communication within the local and broader healthcare community.


































